ACRC Director and Westonian Endowed Professor of Pediatrics, Dr. Wanda Phipatanakul
Wanda Phipatanakul, MD, MS has dedicated her career to clinical research focused on reducing and preventing asthma and allergic diseases in children, particularly inner-city children who often face disproportionate rates of asthma and allergies. In addition to her role as Director of the Clinical Research Center in the Division of Asthma, Allergy, Dermatology, Rheumatology, and Immunology at Boston Children’s Hospital, Dr. Phipatanakul is a Professor of Pediatrics at Harvard Medical School.
Dr. Phipatanakul has authored hundreds of publications in scientific journals, including JAMA and the New England Journal of Medicine. She takes great pride in translating her research findings into actionable ways to improve care for her patients and providing mentorship for the next generation of scientific investigators.
Boston Children’s Hospital
The research consortium at Boston Children’s Hospital consists of over 3,000 researchers. As such, it is the world’s largest research enterprise at a pediatric center. With over a million square feet of research space, $423 million in annual research funding, and more than 100 new inventions each year, Boston Children’s Hospital researchers have the people and resources to better understand disease biology, expand the knowledge of rare diseases, and improve health outcomes across the board.
National Institutes of Health
NIH is part of the U.S. Department of Health and Human Services. It is the largest biomedical research agency in the world. As an ACRC Collaborator, NIH works with ACRC on a number of studies to reduce the severity of asthma and allergies in the population and improve quality of life, and therefore, life expectancies.